Researchers studying the gut microbiome of people who live past 100 keep finding the same name. Akkermansia muciniphila. A single bacterial strain, quietly present in the gut lining of the longest-living people on earth.
It strengthens the gut barrier. It reduces systemic inflammation. And — as a wave of new research now confirms — it stimulates the same hormone that Ozempic and Wegovy were designed to activate.
What Is Akkermansia muciniphila?
Akkermansia muciniphila is a gram-negative bacterium that colonizes the mucus layer lining the gut wall. Unlike most gut bacteria, which feed on dietary contents passing through the intestine, Akkermansia feeds on the mucus layer itself — stimulating the gut to produce more in response. The result is a thicker, more intact barrier between the gut and the bloodstream.
This is not incidental. The integrity of that barrier determines what enters systemic circulation. And what enters systemic circulation determines how fast the body ages.
The GLP-1 Connection
GLP-1 — glucagon-like peptide-1 — is an incretin hormone produced by specialized cells in the gut lining called L-cells. It regulates blood sugar, suppresses appetite, slows gastric emptying, and protects cardiovascular tissue. It is the hormone that semaglutide-based drugs like Ozempic and Wegovy were engineered to mimic.
The question researchers began asking: can the gut produce more of it naturally?
A July 2025 study published in Nutrients found that Akkermansia muciniphila extracts induced a robust, dose-dependent rise in GLP-1 secretion from human L-cells in vitro. The bacterial cell extracts of the strain stimulated both insulin secretion from pancreatic beta cells and GLP-1 secretion from human L-cells — in a dose-dependent manner. One of the latest research studies found a 2,000% increase in GLP-1 secretion from intestinal L-cells. SpringerbioRxiv
This is not the same as injecting semaglutide. The mechanisms differ, the magnitude differs, and human clinical trials specifically measuring GLP-1 outcomes are still accumulating. But the biological logic is clear: Akkermansia acts on the same cellular machinery that GLP-1 drugs target — from the inside, through the gut, without a prescription.
People already on GLP-1 receptor agonists may find the combination particularly relevant, since Akkermansia stimulates endogenous GLP-1 secretion. Additive effects on appetite and blood sugar are biologically plausible. Medical Research Archives
When the Wall Falls
A compromised gut barrier does not announce itself. It leaks quietly.
As Akkermansia declines, the mucus layer thins. Tight junction proteins holding gut cells together begin to loosen. Lipopolysaccharides — fragments of bacterial cell walls — slip through into the bloodstream. The immune system mounts an inflammatory response. Then another. Then another.
This is chronic low-grade inflammation. What researchers call inflammaging — the slow, systemic burn that underlies insulin resistance, cardiovascular disease, non-alcoholic fatty liver disease, and cognitive decline. Not a disease in itself. The soil in which diseases grow.
The chain begins in the gut. It begins with the barrier. And the barrier begins with Akkermansia.
Why It Declines With Age
In healthy adults, Akkermansia accounts for roughly one to four percent of total gut bacteria. In people with obesity, type 2 diabetes, or inflammatory bowel disease, that proportion drops significantly. In older adults, the decline is consistent and well-documented.
The direction of causality remains under study. But the pattern is clear: populations with higher Akkermansia abundance show better metabolic markers, lower systemic inflammation, and longer healthspan. Its repeated appearance in centenarian gut studies is not coincidental.
How to Sustain It Naturally
Akkermansia responds to its environment. The conditions that support it are known.
Polyphenol-rich foods — berries, green tea, dark chocolate, olive oil — consistently correlate with higher Akkermansia abundance. Prebiotic fibers, particularly inulin and pectin, feed the broader microbial ecosystem Akkermansia depends on. Intermittent fasting increases Akkermansia activity through metabolic signaling. What depletes it is equally clear: high-fat, high-sugar diets, chronic sleep deprivation, antibiotic overuse, and persistent stress.
The Two Products Worth Knowing
Two companies have brought DNA-sequenced Akkermansia to market. They differ in one fundamental way: one delivers live bacteria, the other delivers pasteurized.
Pendulum Akkermansia is the leading live-strain product. Manufactured in a strict, oxygen-free facility in the U.S., it uses anaerobic technology to keep this fragile strain viable through digestion. Pendulum is the first consumer microbiome company to co-develop a clinical registry with the Mayo Clinic. The product pairs live Akkermansia with inulin to support colonization. NutraIngredients.com
The Akkermansia Company is the pasteurized option, founded by the research team that first isolated and named the strain. Pasteurization enhances the accessibility of Amuc_1100 — the surface protein responsible for much of Akkermansia’s barrier-strengthening and GLP-1 stimulating effect. Clinical data shows the pasteurized form performs comparably to live bacteria, with greater stability and no refrigeration required. It holds the only EFSA approval for an Akkermansia product in Europe.
Neither is definitively superior. The choice depends on individual gut status and whether live colonization or protein-level signaling is the priority.
→ [Pendulum Akkermansia — Live Strain]
→ [The Akkermansia Company — Pasteurized]
This post contains affiliate links. A commission may be earned on qualifying purchases. Product selection is editorially independent.
Not a Supplement Story
Akkermansia is not a supplement trend. It is a structural variable in the biology of aging — one that appears, reliably, in the guts of people who live longest.
The mucus layer is not a detail. It is the boundary between the gut and the bloodstream. Between local digestion and systemic inflammation. Between a body that ages quietly and one that does not.
Sustain the barrier. Everything else follows.
Frequently Asked Questions
What is Akkermansia muciniphila?
Akkermansia muciniphila is a gram-negative bacterium that colonizes the mucus layer of the gut. It strengthens the intestinal barrier by stimulating mucus production, reduces intestinal permeability, and is associated with lower systemic inflammation and improved metabolic health.
Does Akkermansia increase GLP-1?
Yes. Research published in Nutrients in 2025 found that Akkermansia muciniphila cell extracts stimulated GLP-1 secretion from human intestinal L-cells in a dose-dependent manner. Akkermansia acts on the same L-cells that produce GLP-1 naturally — the same cells targeted by drugs like Ozempic and Wegovy. bioRxiv
Is Akkermansia a natural alternative to Ozempic?
Not directly. Ozempic (semaglutide) is a pharmaceutical GLP-1 receptor agonist with clinically documented weight loss effects. Akkermansia stimulates the body’s own GLP-1 production through gut signaling — a different mechanism, with more modest and indirect effects. It is more accurately described as a natural GLP-1 support strategy than a replacement for prescription medication.
What is the difference between live and pasteurized Akkermansia supplements?
Live Akkermansia supplements deliver viable bacteria capable of colonizing the gut. Pasteurized Akkermansia delivers heat-killed bacteria whose surface proteins — particularly Amuc_1100 — remain intact and biologically active. Clinical data suggests comparable efficacy between the two forms.
Which foods increase Akkermansia naturally?
Polyphenol-rich foods including berries, green tea, dark chocolate, and olive oil are associated with higher Akkermansia abundance. Prebiotic fibers such as inulin and pectin also support its growth.
What depletes Akkermansia in the gut?
High-fat and high-sugar diets, antibiotic use, chronic sleep deprivation, and persistent psychological stress are the primary factors associated with Akkermansia depletion.
Is Akkermansia safe to supplement?
Current clinical evidence indicates that both live and pasteurized Akkermansia supplementation is well-tolerated in healthy adults. The pasteurized form has received EFSA approval in Europe.
Next: Butyrate — the molecule Akkermansia helps produce, and why it may be the single most important metabolite in the aging gut.
The Long Becoming.
For those who intend to last.